Among all DAPI-positive and CD45-negative cells (average size 20 μm), α-MVP was able to detect approximately 51% of them (the second row in Fig. 5 and Table 2), suggesting that csMVP-positive CTCs are approximately half of all putative CTCs in HCC patients. Here, PTPRC is linked to hepatocellular carcinoma.